The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
The coronavirus disease 2019 (COVID-19) has caused enormous health risks and global economic disruption. This disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 nucleocapsid protein is a structural protein involved in viral replication and assembly....
Saved in:
| Main Authors: | Haiyun Yu, Fei Guan, Heather Miller, Jiahui Lei, Chaohong Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2022.2164219 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation of recombinant SARS-CoV-2 nucleocapsid protein
by: A. S. Yakovleva, et al.
Published: (2025-03-01) -
Screening and identification of host factors interacting with the nucleocapsid protein of SARS-CoV-2 omicron variant using the yeast two-hybrid system
by: Chunhua Wang, et al.
Published: (2025-08-01) -
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination
by: Sebastian J Theobald, et al.
Published: (2022-07-01) -
Dynamic Interaction Between SARS-CoV-2 and Influenza A Virus Infection in Human Respiratory Tissues and Cells
by: John C. W. Ho, et al.
Published: (2025-04-01) -
Individuals Infected with SARS-CoV-2 Prior to COVID-19 Vaccination Maintain Vaccine-Induced RBD-Specific Antibody Levels and Viral Neutralization Activity for One Year
by: Christina S. Mcconney, et al.
Published: (2025-04-01)